These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 17290726
1. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Croghan IT, Hurt RD, Dakhil SR, Croghan GA, Sloan JA, Novotny PJ, Rowland KM, Bernath A, Loots ML, Le-Lindqwister NA, Tschetter LK, Garneau SC, Flynn KA, Ebbert LP, Wender DB, Loprinzi CL. Mayo Clin Proc; 2007 Feb; 82(2):186-95. PubMed ID: 17290726 [Abstract] [Full Text] [Related]
3. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. Hurt RD, Krook JE, Croghan IT, Loprinzi CL, Sloan JA, Novotny PJ, Kardinal CG, Knost JA, Tirona MT, Addo F, Morton RF, Michalak JC, Schaefer PL, Porter PA, Stella PJ. J Clin Oncol; 2003 Mar 01; 21(5):914-20. PubMed ID: 12610193 [Abstract] [Full Text] [Related]
4. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Ferguson SG, Gitchell JG, Shiffman S, Sembower MA. Clin Ther; 2009 Sep 01; 31(9):1957-65. PubMed ID: 19843485 [Abstract] [Full Text] [Related]
5. The nicotine inhaler in smoking cessation. Hjalmarson A, Nilsson F, Sjöström L, Wiklund O. Arch Intern Med; 2009 Sep 01; 157(15):1721-8. PubMed ID: 9250233 [Abstract] [Full Text] [Related]
7. A bupropion smoking cessation clinical trial for cancer patients. Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F. Cancer Causes Control; 2010 Jun 01; 21(6):811-20. PubMed ID: 20087643 [Abstract] [Full Text] [Related]
8. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G. Addiction; 2004 Sep 01; 99(9):1206-18. PubMed ID: 15317642 [Abstract] [Full Text] [Related]
10. [Effect of treatment for nicotine dependence in patients with COPD]. Górecka D, Bednarek M, Nowiński A, Puścińska E, Goljan-Geremek A, Zieliński J. Pneumonol Alergol Pol; 2003 Sep 01; 71(9-10):411-7. PubMed ID: 15052977 [Abstract] [Full Text] [Related]
11. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. Killen JD, Robinson TN, Ammerman S, Hayward C, Rogers J, Stone C, Samuels D, Levin SK, Green S, Schatzberg AF. J Consult Clin Psychol; 2004 Aug 01; 72(4):729-35. PubMed ID: 15301658 [Abstract] [Full Text] [Related]
12. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. Lancet; 2016 Jun 18; 387(10037):2507-20. PubMed ID: 27116918 [Abstract] [Full Text] [Related]
13. The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial. Walker N, Howe C, Bullen C, Grigg M, Glover M, McRobbie H, Laugesen M, Parag V, Whittaker R. Addiction; 2012 Oct 18; 107(10):1857-67. PubMed ID: 22594651 [Abstract] [Full Text] [Related]
14. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Becker KM, Rose JE, Albino AP. Nicotine Tob Res; 2008 Jul 18; 10(7):1139-48. PubMed ID: 18629723 [Abstract] [Full Text] [Related]
15. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study. Kalman D, Herz L, Monti P, Kahler CW, Mooney M, Rodrigues S, O'Connor K. Drug Alcohol Depend; 2011 Nov 01; 118(2-3):111-8. PubMed ID: 21507585 [Abstract] [Full Text] [Related]
16. A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Wallström M, Nilsson F, Hirsch JM. Addiction; 2000 Aug 01; 95(8):1161-71. PubMed ID: 11092064 [Abstract] [Full Text] [Related]
17. Efficacy of bupropion alone and in combination with nicotine gum. Piper ME, Federman EB, McCarthy DE, Bolt DM, Smith SS, Fiore MC, Baker TB. Nicotine Tob Res; 2007 Sep 01; 9(9):947-54. PubMed ID: 17763111 [Abstract] [Full Text] [Related]
18. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. Cox LS, Patten CA, Niaura RS, Decker PA, Rigotti N, Sachs DP, Buist AS, Hurt RD. J Gen Intern Med; 2004 Aug 01; 19(8):828-34. PubMed ID: 15242467 [Abstract] [Full Text] [Related]
19. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. McCarthy DE, Piasecki TM, Lawrence DL, Jorenby DE, Shiffman S, Fiore MC, Baker TB. Nicotine Tob Res; 2008 Apr 01; 10(4):717-29. PubMed ID: 18418793 [Abstract] [Full Text] [Related]
20. Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation. Nielsen K, Fiore MC. Prev Med; 2000 Mar 01; 30(3):209-16. PubMed ID: 10684744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]